戻る Agenda
Evaluating Sites for Optimum Site Selection and Performance
Session Chair(s)
Scott R Martin, JD
Principal
KMR Group Inc., United States
The session highlights how site metrics can be used to reduce risk, shorten timelines and increase productivity in clinical trials. We will explore best practices in the use of site metrics for global site selection. We will identify ways site metrics can assist in shaping strategy, defining site goals and setting timelines to meet enrollment objectives. We will also explore how quantitative analysis of performance criteria can impact the success of your sites, and your trial.
Learning Objective : Outline types of site metrics used for site selection, planning and evaluation; Identify the role of site scorecards and how they can be integrated into the recruitment process; Explain how site metrics can be used to improve enrollment timelines.
Speaker(s)
Using Site Metrics to Enhance Site Performance
Scott R Martin, JD
KMR Group Inc., United States
Principal
A Case Study: Strategies for Optimizing Site Selection
Elizabeth Desrosiers, MS, PMP
Merck Research Laboratories, United States
Director, Global Trial Management
New Approaches to Site Feasibility
Douglas A Swain, RPH
Genentech, A Member of the Roche Group, United States
Senior Functional Manager, Northeast Region